These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16489936)

  • 1. The effect of image size on screen-positive rates for nuchal translucency screening.
    Teoh M; Meagher SE; Choong S; Shekleton P; Wallace EM
    BJOG; 2006 Apr; 113(4):479-81. PubMed ID: 16489936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
    Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
    Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness.
    Vandecruys H; Faiola S; Auer M; Sebire N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Jun; 25(6):551-3. PubMed ID: 15880648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tissue harmonic imaging on measurement of nuchal translucency thickness.
    Pasquini L; Tondi F; Rizzello F; Pontello V; Paoletti E; Fontanarosa M
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):423-6. PubMed ID: 20205154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
    Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    Prenat Diagn; 2005 May; 25(5):411-6. PubMed ID: 15906410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of image size on nuchal translucency measurement.
    Edwards A; Mulvey S; Wallace EM
    Prenat Diagn; 2003 Apr; 23(4):284-6. PubMed ID: 12673630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of nuchal translucency measurement depends on equipment used and its calibration.
    Axell RG; Gillett A; Pasupathy D; Chudleigh T; Brockelsby J; White PA; Lees CC
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):31-7. PubMed ID: 24448754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening.
    Sahota DS; Leung WC; To WK; Chan WP; Lau TK; Leung TY
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1039-43. PubMed ID: 21854135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland.
    Peuhkurinen S; Laitinen P; Honkasalo T; Ryynanen M; Marttala J
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):769-74. PubMed ID: 23369035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of sonographer nuchal translucency measurement performance--central tendency and dispersion.
    Sahota DS; Chen M; Leung TY; Chan LW; Fung TY; Ting YH; Lau TK
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):812-6. PubMed ID: 21265719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miscarriage after a normal scan at 12-14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening.
    Westin M; Källén K; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):728-36. PubMed ID: 17823976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis.
    Koster MP; Wortelboer EJ; Engels MA; Stoutenbeek PH; Elvers LH; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2009 Aug; 34(2):136-41. PubMed ID: 19562664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization.
    Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; de Jonge ET; Ombelet WU; Nijhuis JG
    Ultrasound Obstet Gynecol; 2004 Oct; 24(5):511-5. PubMed ID: 15459938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.